Industrial and Commercial Bank of China Limited (1398.HK) vs AbbVie Inc. (ABBV)

Industrial and Commercial Bank of China Limited is one of China’s largest state-controlled commercial banks. It provides corporate banking, personal banking, wealth management, payments, and treasury services through a broad domestic and international network. The bank serves major companies, public-sector entities, small businesses, and retail customers. Its results are influenced by Chinese credit growth, interest-rate spreads, asset quality, government policy, and the health of the country’s property, infrastructure, and industrial sectors.

AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.